Fundz

Exicure, Inc. Enters Into Definitive Agreement With Cbi Usa, Inc. For $5.4 Million Equity Financing And Announces Implementation Of Strategic Measure To Reduce Cash Burn And Prioritize Strategic Alternatives

PUBLIC · XCURSep 26, 2022

Amount Raised

$5.4 Million

Round Type

Venture

SkokieOtherBiotechnologyHealth CareTherapeutics

Description

Exicure, Inc. (NASDAQ: XCUR) today announced plans to restructure the Company and align resources to continue exploring strategic alternatives that maximize stockholder value. After a strategic review of the Company’s business plans and objectives and its existing cash resources, the Company’s Board of Directors has approved the following:

Quick answer

EXICURE, INC. raised $5.4 Million in a funding round, dated September 26, 2022. EXICURE, INC. is based in Skokie, Illinois, United States.

How much did EXICURE, INC. raise?
EXICURE, INC. raised $5.4 Million in a funding round on September 26, 2022.
What does EXICURE, INC. do?
Exicure is developing a new class of immunomodulatory and gene silencing drugs against validated targets.
Where is EXICURE, INC. based and how big is it?
EXICURE, INC. is based in Skokie, Illinois, United States. Fundz records about 8 employees.
Who are the decision-makers at EXICURE, INC?
Fundz holds 2 contacts at EXICURE, INC., including the Chief Accounting Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as EXICURE, INC. that raised within 45 days of this round, from Fundz verified event records.

  • Lipidio Pharmaceuticals raised an undisclosed amount (Series A) on November 10, 2022.
  • NRG Therapeutics raised $18M (Series A) on November 9, 2022.
  • Kinimmune raised an undisclosed amount (Funding Round) on November 9, 2022.
  • NRx Pharmaceuticals raised $11M (Debt Financing) on November 7, 2022.
  • Zenas BioPharma raised $118M (Funding Round) on November 7, 2022.
  • MBX Biosciences, Inc. raised $47M on November 7, 2022.

Who to call at EXICURE, INC., and when

A new round usually means EXICURE, INC. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day EXICURE, INC. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at EXICURE, INC., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at EXICURE, INC.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

EXICURE, INC.

Location

8045 LAMON AVE, SUITE 410

Skokie, Illinois, United States

About

Exicure is developing a new class of immunomodulatory and gene silencing drugs against validated targets.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment EXICURE, INC. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsJosh M., Chief Accounting Officer hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for EXICURE, INC.'s next move

See what Strategic adds

EXICURE, INC. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.